Skip to main content
ALHC
NASDAQ Life Sciences

General Atlantic Affiliate to Sell 13.2M Alignment Healthcare Shares in Secondary Offering

feedReported by Reuters
Sentiment info
Negative
Importance info
7
Price
$19.01
Mkt Cap
$3.932B
52W Low
$11.625
52W High
$23.87
Market data snapshot near publication time

summarizeSummary

An affiliate of General Atlantic, L.P. has announced a secondary offering of 13.2 million shares of Alignment Healthcare. This event follows the company's recent positive Q4 and full-year 2025 earnings report on February 26, 2026. Secondary offerings of this magnitude by a significant investor typically create selling pressure on the stock due to increased supply and can be perceived negatively as a major shareholder reduces their stake. Traders will closely watch the pricing of the offering and the market's reaction to assess the immediate impact on ALHC's valuation.

At the time of this announcement, ALHC was trading at $19.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $11.63 to $23.87. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed ALHC - Latest Insights

ALHC
Apr 24, 2026, 10:52 AM EDT
Filing Type: DEF 14A
Importance Score:
7
ALHC
Mar 04, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
ALHC
Mar 03, 2026, 3:13 PM EST
Filing Type: 424B7
Importance Score:
7
ALHC
Mar 02, 2026, 9:05 PM EST
Source: GlobeNewswire
Importance Score:
7
ALHC
Mar 02, 2026, 4:49 PM EST
Source: Reuters
Importance Score:
7
ALHC
Feb 26, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
8
ALHC
Jan 12, 2026, 9:10 AM EST
Filing Type: 8-K
Importance Score:
7